SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046572
Filing Date
2023-12-29
Accepted
2023-12-29 16:05:36
Documents
12
Period of Report
2023-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35995
  Complete submission text file 0001493152-23-046572.txt   210600

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ltrn-20231229.xsd EX-101.SCH 3030
3 XBRL LABEL FILE ltrn-20231229_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ltrn-20231229_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3409
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 231527681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)